Wayne Weisman - 20 Apr 2021 Form 4/A - Amendment Insider Report for Recro Pharma, Inc. (SCTL)

Role
Director
Signature
/s/ Ryan D. Lake, Attorney-in-fact
Issuer symbol
SCTL
Transactions as of
20 Apr 2021
Transactions value $
$0
Form type
4/A - Amendment
Filing time
17 May 2021, 16:09:37 UTC
Date Of Original Report
22 Apr 2021
Next filing
27 May 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SCTL Stock Option (right to buy) Award $0 +38K $0.00 38K 20 Apr 2021 Common Stock 38K $2.60 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This amended Form 4 is being filed to correct a typographical error in the exercise price of the stock options acquired on April 20, 2021 as reported on the Form 4 filed on April 22, 2021.
F2 The stock option will vest on April 20, 2022.